Figures
Abstract
In this study, we investigated the potential of Lactobacillus plantarum isolated from Chinese traditional fermented foods to reduce the toxicity of aflatoxin B1 (AFB1), and its subsequent detoxification mechanism. Among all the investigated L. plantarum strains, L. plantarum C88 showed the strongest AFB1 binding capacity in vitro, and was orally administered to mice with liver oxidative damage induced by AFB1. In the therapy groups, the mice that received L. plantarum C88, especially heat-killed L. plantarum C88, after a single dose of AFB1 exposure, showed an increase in unabsorbed AFB1 in the feces. Moreover, the effects of L. plantarum C88 on the enzymes and non-enzymes antioxidant abilities in serum and liver, histological alterations of liver were assayed. The results indicated that compared to the control group, L. plantarum C88 alone administration induced significant increase of antioxidant capacity, but did not induce any significant changes in the histological picture. Compared to the mice that received AFB1 only, L. plantarum C88 treatment could weaken oxidative stress by enhancing the activity of antioxidant enzymes and elevating the expression of Glutathione S-transferase (GST) A3 through Nuclear factor erythroid (derived factor 2) related factor 2 (Nrf2) pathway. Furthermore, cytochrome P450 (CYP 450) 1A2 and CYP 3A4 expression was inhibited by L. plantarum C88, and urinary aflatoxin B1-N7-guanine (AFB-N7-guanine), a AFB1 metabolite formed by CYP 1A2 and CYP 3A4, was significantly reduced by the presence of viable L. plantarum C88. Meanwhile, the significant improvements were showed in histological pictures of the liver tissues in mice orally administered with viable L. plantarum C88. Collectively, L. plantarum C88 may alleviate AFB1 toxicity by increasing fecal AFB1 excretion, reversing deficits in antioxidant defense systems and regulating the metabolism of AFB1.
Citation: Huang L, Duan C, Zhao Y, Gao L, Niu C, Xu J, et al. (2017) Reduction of Aflatoxin B1 Toxicity by Lactobacillus plantarum C88: A Potential Probiotic Strain Isolated from Chinese Traditional Fermented Food “Tofu”. PLoS ONE 12(1): e0170109. https://doi.org/10.1371/journal.pone.0170109
Editor: Salah A. Sheweita, Alexandria University, EGYPT
Received: May 15, 2016; Accepted: December 29, 2016; Published: January 27, 2017
Copyright: © 2017 Huang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are within the paper and its Supporting Information files.
Funding: This work was financially supported by Modern Agroindustrial Technology Research Systems in China (CARS-37), National Public Benefit Research (Agriculture) Foundation (201303085), and Jilin Agricultural Innovation Project (52110302). SL received the fundings. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Introduction
Aflatoxin B1 (AFB1) is considered to possess the highest toxicity among various types of secondary metabolites produced by a larger number of Aspergillus spp, and classified as a Group I carcinogen for humans by the International Agency for Research on Cancer [1]. Many foods such as grains (corn, sorghum, and millet), peanuts, beans, and nuts (almonds, pistachios, etc.) may support the growth of Aspergillus, and may be contaminated with aflatoxins. It has been reported that AFB1 could induce growth retardation, hepatocellular carcinoma, and immunosuppression [2,3]. Relevant studies indicated that AFB1 was predominantly metabolized by cytochrome P450 (CYP 450) enzyme systems after being absorbed in the intestinal tract. Subsequently, under the action of CYP 450, including cytochrome P450 (CYP 450) 1A2 and CYP 3A4, AFB1 was transformed to exo-AFB1-8,9-epoxide (AFBO), which could bind to DNA, proteins, and other critical cellular macromolecules to exert its carcinogenic effect [4]. However, AFB1 also could be converted to aflatoxin Q1 (AFQ1) by CYP 3A4, or aflatoxin M1 (AFM1) by CYP 1A2, which would be considered one way of detoxification. It was also found that glutathione conjugation could eliminate AFBO through the catalytic action of glutathione S-transferase (GST), which was activated by Nrf2-Antioxidant Response Element (ARE) response [5]. Furthermore, GST A3 appeared to be the critical factor involved in AFB1 detoxification in mice [6].
It has been reported that some lactic acid bacteria (LAB) can remove AFB1 or have protective effects against AFB1. Some relevant studies demonstrated that lactobacilli could inhibit the production of aflatoxin as well as the growth of Aspergillus spp [7, 8]. Some researchers also analyzed AFB1 removal by lactobacilli in vitro and pointed out that lactobacilli could rapidly remove AFB1 with a removal rate of approximately 50–80% [9–11]. A study using rat as the animal model suggested that probiotic treatment prevented weight loss and reduced the hepatotoxic effects caused by a high dose of AFB1 by increasing the excretion of orally administered aflatoxin via the fecal route [1, 12]. Another study reported that use of LAB induced protective effects against the oxidative stress and toxicity of AFB1 in part through adhesion [13]. Although lactobacilli can provide protective effects against AFB1, the mechanism underlying such protection against AFB1 is rarely reported yet, specially the molecular mechanisms of oxidative stress-related pathways.
L. plantarum C88 (CCTCC NO: M 209254), isolated from Chinese traditional fermented dairy Tofu (a Chinese traditional cheese), has exhibited favorable probiotic properties, including aciduricity, bile resistance and ability to colonize in the gastrointestinal tracts. Our previous experiments showed that L. plantarum C88 had strong radical scavenging activities, and administration of L. plantarum C88 significantly improved the antioxidant status of the D-galatose induced oxidatively stress mice [14]. On the basis of these special functions, L. plantarum C88 seem to have potency against AFB1 toxicity. Therefore, in this study we evaluated the detoxification effects of L. plantarum C88 on AFB1 toxicity and examined the underlying mechanisms.
Materials and Methods
2.1 Microorganisms, media, and cultivation conditions
Ten strains of LAB were used in this study, where L. plantarum C4, C18, C23, C25, C26 and C88 were isolated from Inner Mongolia traditional fermented dairy Tofu and L. plantarum S2-13, S3-9, S4-7 and S5-16 were isolated and identified from Chinese traditional fermented sauerkraut [14]. All the strains were grown in Man–Rogosa–Sharpe (MRS) broth (Hopebio Co., Qingdao, China) at 37°C for 16 h and stored at 4°C between transfers. The bacteria were harvested by centrifugation (2000 × g, 10 min, 4°C), washed twice and resuspended to adjust a density of 1010 colony-forming units (CFU)/mL using phosphate-buffered saline (PBS, pH 7.2) (Hopebio Co., Qingdao, China). The viable bacterial samples (1010 CFU/mL) were autoclaved at 121°C for 30 min to obtain heat-killed bacterial samples, according to the method described by Choi et al. [15].
2.2 AFB1 binding assay in vitro
The binding assay was performed following the procedure reported by Haskard et al. [10]. The bacterial pellets (viable and heat-killed, 1010 CFU/mL) were suspended in AFB1 solution (2 μg/mL), and incubated at 37°C for 30 min in a shaking bath (200rpm/min). The bacteria were again pelleted by centrifugation (2000 × g, 10 min, 4°C), and the supernatant containing unbound AFB1 was collected for high-performance liquid chromatography (HPLC) analysis, which was similar to the analysis described by Samuel et al. [16]. Briefly, the methanol-water (1:1, v/v) was used as the mobile phase at a flow rate of 1 mL/min. Separation was achieved using a C18 column (150 mm × 4.6 mm, 5-μm particle size, Agilent, USA) at 30°C with an injection volume of 20 μL. AFB1 detection was accomplished using an ultraviolet detector at 360 nm.
2.3 In vivo assessment of AFB1 removal assay
2.3.1 Animals and experimental design.
On the basis of in vitro AFB1 removal assay, L. plantarum C88 with the highest percentage of binding AFB1 was selected for further in vivo assessment. Male ICR mice (6 weeks’ old, 18–22 g) were randomly divided into six groups (n = 15, per group). All animal procedures were approved by the Institutional Animal Care and Use Committee of Jilin University (SCXK 2015–0001). Animals were housed under standard conditions (25°C, 12 h light/dark cycle, relative humidity 50% ± 5%), and were allowed free access to food and water during the experimental period. After an acclimatization period of 1 week, the viable or heat-killed C88 group respectively received 4.0 × 1010 CFU/kg bw (body weight) viable or heat-killed L. plantarum C88 by gavage, the AFB1 group mice received 300 μg AFB1/kg bw, in the therapy groups, the same dose of the viable or heat-killed L. plantarum C88 was administered after 300 μg AFB1/kg bw exposure (AFB1 + Viable or Heat-killed C88) for 21 days continuously. The control mice received normal saline.
At the end of experimental period (day 21), all the mice were anesthetized by inhalation of diethyl ether, blood samples were collected from retro-orbital venous plexus for the determination. After blood samples were collected, all mice were killed by cervical dislocation. Serum was obtained by centrifugation (2000 × g, 10 min, 4°C) and stored at −80°C for further analysis; 10% liver homogenates were prepared by homogenizing frozen tissue in cold normal saline. The homogenates were centrifuged (2000 × g, 10 min, 4°C), and the proteins in liver homogenates were determined by the bicinchonininc acid (BCA) protein assay reagent (Dingguo Changsheng Biotech Co., Beijing, China). The remaining part of the liver tissue was divided into two parts: fixed for 48 h in 10% formalin saline for histopathological studies, and stored at −80°C for quantitative real-time polymerase chain reaction (PCR) and Western blot analysis.
2.3.2 Modulation of intestinal absorption, fecal excretion and metabolism of AFB1.
After the mice were administered AFB1 and L. plantarum C88 on the first day, the feces and urine were collected per hour for 7 h continuously. Then, the AFB1 content or the number of lactobacilli in feces was measured. Urine of mice was stored at -20°C, and aflatoxin-N7-guanine levels in urine were measured by HPLC.
AFB1 content in fecal samples was measured using the method reported by Mykkänen et al. [17] with slight modifications. Briefly, the feces were frozen using liquid nitrogen, ground into powder, and homogenized with five volumes of benzene-acetonitrile (97:3, v/v). After centrifugation (2000 × g, 15 min, 4°C) and filtration, the supernatant containing AFB1 was lyophilized, and then the lyophilized powder was dissolved in 500 μL of methanol for HPLC analysis as described at Section 2.2.
To determine the number of lactobacilli in feces, the collected fecal samples were immediately stored at 4°C and analyzed using the method described by Wang et al. [18]. Briefly, the viable lactobacilli in feces were determined by dilution plating with MRS agar medium incubated at 37°C for 48 h. The colonies were identified by classificatory characteristics in morphology, Gram stain and catalase test.
Urine samples were acidified with 1 N HCl and 1 M ammonium formate to pH 5, centrifuged (3000 × g, 15 min, 4°C), and then passed through a Sep-Pak C18 cartridges (Waters, USA), and the cartridge was washed with 10 ml of 5% methanol–water. Aflatoxin-N7-guanine were eluted from the cartridge using 40% acidic acetonitrile (acetic acid:acetonitrile: water 1:40:60). The eluant was extracted twice with dichloromethane, and the extracts were lyophilized. Lyophilized powder was dissolved in 30% acetonitrile/ methanol (1:1, v/v) in 20 mM ammonium acetate buffer (pH 3.9) for HPLC analysis. Reversed-phase HPLC with fluorescence detection was used to measure the aflatoxin-N7-guanine level in urine as described by Mykkänen et al. [16].
2.3.3 Antioxidant enzyme assays.
Total antioxidant capacity (T-AOC), total superoxide dismutase (T-SOD) activity, glutathione peroxidase (GSH-Px) activity, catalase (CAT) activity, and malondialdehyde (MDA) levels in serum and liver were determined spectrophotometrically using commercially available assay kits (Nanjing Jiancheng Bioengineering Institute, China) following the manufacturer’s protocols.
2.3.4 Histopathological studies.
Livers were fixed for 48 h in 10% formalin saline. Tissues were embedded in paraffin and sectioned at 5 μm thickness using a rotary microtome. Sections were stained with hematoxylin-eosin (H&E) for light microscopy examination.
2.3.5 Quantitative real-time PCR analysis.
Total RNAs were extracted from tissues using TRIzol reagent (ComWin Biotech Co., Beijing, China) and reverse-transcribed into cDNA using M-MLV reverse-transcriptase (Promega Biotech Co., Beijing, China). Real-time PCR analysis was performed with FastStart Universal SYBR Green Master (Roche Diagnostics GmbH, Mannheim, Germany) and gene-specific forward and reverse primers on a LightCycler 96 Real-Time PCR system (Roche Diagnostics GmbH, Mannheim, Germany). The primers PCR conditions for CYP 1A2, CYP 3A4, GST A3, Nrf2, and β-actin were 95°C for 3 min, 40 cycles of 95°C for 15 s, and 60°C for 1 min. Primer sequences for real-time PCR are shown in Table 1.
2.3.6 Western blot analysis.
Freshly isolated liver tissue was homogenized in lysis buffer supplemented with protease inhibitors (ComWin Biotech Co., Beijing, China). Nrf2 was extracted using a nuclear fractionation isolation kit (ComWin Biotech Co., Beijing, China). This homogenate was further mixed with buffer [60mM Tris-HCl, 2% sodium dodecyl sulfate (SDS) and 2% β- mercaptoethanol, pH 7.2] and boiled for 10 min. The protein content was determined using BCA protein assay reagent (Dingguo Changsheng Biotech Co., Beijing, China). A 50-μg sample of protein was applied to 10% SDS-polyacrylamide gel electrophoresis and transferred to a nitrocellulose membrane (Millipore, MA, USA) for 90 min. Membranes were blocked with 5% skimmed milk in Tris-buffered saline (TBST) and incubated with primary antibodies, including anti-CYP 1A2, anti-CYP 3A4, anti-GST A3, anti-Nrf2 (Biosynthesis Biotech Co., Beijing, China), and anti-β-actin (ComWin Biotech Co., Beijing, China), for 12 h at 4°C, followed by reaction with horseradish peroxidase-conjugated antibody for 1 h at 37°C. The detected bands were quantified using an image analyzer (ChemiScope 5600, Clinx Science Instruments, Shanghai, China), and β-actin was used as a loading control.
2.4 Neutralization
The spleen was aseptically removed from ICR mouse and splenocytes were homogenized in Roswell Park Memorial Institute (RPMI) 1640 medium containing 10% heat-inactivated fetal bovine serum (Hao Yang Biological Manufacture Co., Tianjin, China) and 1% Amphotericin B (MP Biomedicals, France). Erythrocytes were lysed with lysis buffer (Beijing Solarbion Science & Technology Co., Ltd., China) for 1 min at 4°C. Single-cell suspensions (106 cells/well) were cultured in a 6-well culture plate at 37°C, 5% CO2 incubator.
To examine the effects of Nrf2 on antioxidant response, neutralization test was performed. 5 mg/ml of purified rabbit anti-mouse Nrf2 monoclonal antibody (Biosynthesis Biotech Co., Beijing, China) or L. plantarum C88 (1010 CFU/ml) were added into splenocytes cells to co-cultivate for 1h. Then, the cells were cultured in the presence of AFB1 (2 μg/ml) for 48h. As the positive and negative control (C88 and AFB1 groups), splenocytes cells were treated with L. plantarum C88 or AFB1 for 48 h. The untreated splenocytes cells were used as a control. Cell suspensions were centrifuged at 300 × g for 5 min at day 2. Supernatants were collected for antioxidant enzyme assays and the cells were used to test the expression of GST A3 by the methods as described at Section 2.3.3–2.3.5. In addition, Western-blot (Section 2.3.5) was used to detect the Nrf2 level in splenocytes at day 2.
2.5 Statistical analyses
Experimental data were expressed as means and standard errors (means ± standard error) for each group. Differences between groups were analyzed using one-way analysis of variance (ANOVA), followed by the Tukey post hoc test. P value <0.05 was considered to be statistically signifcant.
Results
3.1 The binding ability of bacteria with AFB1
The binding ability of 10 strains with AFB1 was examined, and the results are shown in Fig 1. All the strains showed certain binding activities with AFB1. The binding rates of different strains (viable and heat-killed bacteria) with AFB1 ranged from 20.88% to 59.44%. The differences in binding ability between viable and nonviable cells were not statistically significant in most of the assays, in addition to C4, C26 and S3-9. The heat-killed bacteria showed higher binding ability with AFB1 compared with viable bacteria. L. plantarum C88 demonstrated significantly high binding ability with AFB1 compared with the other strains (P < 0.05); thus, it was selected for further study.
The results are expressed as mean ± S.D. The different letters in the same rows mean significant difference (p<0.05).
3.2 Reduction of intestinal absorption of AFB1
The effects of L. plantarum C88 on cultivable bacteria and AFB1 contents in feces in 7 h after the initial treatments on the first day are shown in Table 2. The number of cultivable bacteria and the concentration of AFB1 in the feces were positively associated. Compared with AFB1 group, oral administration of viable or heat-killed L. plantarum C88 significantly increased AFB1 contents in feces at each time point (P < 0.05). Compared with AFB1 group, urinary excretion of AFB-N7-guanine was significantly reduced by the presence of viable L. plantarum C88. In mice receiving AFB1 plus heat-killed L. plantarum C88, the levels of AFB-N7-guanine were lower than in those receiving only AFB1, though those were not statistically significant.
3.3 Alleviation oxidative stress
The effects of different treatments on T-AOC, T-SOD, GSH-Px, CAT, and MDA in serum and liver are presented in Table 3. In the groups only treated with viable or heat-killed L. plantarum C88, T-AOC, T-SOD, GSH-Px, and CAT activities in serum and liver were increased and MDA content in serum and liver were decreased in comparison with control group. In the therapy groups, mice administered viable or heat-killed L. plantarum C88 showed the significant increase (P < 0.05) in T-AOC in serum and liver when compared to AFB1 treated group. Furthermore, the group orally administrated AFB1 plus viable L. plantarum C88 showed higher T-AOC in serum compared with the control group. The group orally administrated AFB1 plus viable L. plantarum C88 showed the significant increased (P < 0.05) in T-SOD, GSH-Px, and CAT activities in serum and liver compared with the AFB1 group. The elevation of MDA content in serum and liver was inhibited after treatment with viable or heat-killed L. plantarum C88, and this effect seemed to be more pronounced in mice treated with viable L. plantarum C88.
3.4 Histopathological studies
No serious tissue damage in the liver was observed in viable and heat-killed L. plantarum C88 groups. AFB1 exposure caused significant damage to the liver, including loss of hepaticcord, cytoplasmic vacuolization, and necrosis of hepatocytes. AFB1 and viable L. plantarum C88 co-treatment group significantly alleviated such hepatic injury, whereas the histological changes in the AFB1 plus heat-killed L. plantarum C88 group was not so evident (Fig 2). These results indicate that C88 supplementation mitigates AFB1 induced liver injury.
(a) Hepatic tissue of mice in the control group, with the normal histological structure of liver lobule; (b) hepatic tissue of mice in the AFB1 group, with loss of intact liver plates, cytoplasmic vacuolization, cytolysis, and necrosis of hepatocytes; (c) mice treated with viable C88 showing normal hepatocytes and portal tract; (d) mice treated with heat-killed C88 showing nearly normal hepatocytes and portal tract; (e) hepatic tissue of mice in the AFB1 plus viable L. plantarum C88 therapy group, with alleviation of cytoplasmic vacuolization and no necrosis of hepatocytes; (f) hepatic tissue of mice in the AFB1 plus heat-killed L. plantarum C88 therapy group, with less hepatic injury. H&E staining was used (magnification 400×).
3.5 Inhibition of CYP 1A2 and CYP 3A4 expression
To confirm whether the biotransformation of AFB1 could be inhibited by L. plantarum C88, the expression of CYP 1A2 and CYP 3A4 was detected (Fig 3). After co-treatment with AFB1 and viable L. plantarum C88, a significantly decreased expression of CYP 1A2 and CYP 3A4 could be observed compared with the AFB1 group. Down-regulation of CYP 1A2 and CYP 3A4 was presumed to be a protective mechanism different from the activation of detoxification. The results of Western blot confirmed the aforementioned findings.
CYP 1A2 (A) and CYP 3A4 (B) gene expression was measured by RT-PCR. Expression of CYP 1A2 (C), CYP 3A4 (D) and β-actin was detected by Western blot analysis. β-actin was used as a housekeeping control. The results are expressed as mean ± S.D.; each data point is the average of 3 repeated measurements from 10 independently replicated experiments (n = 10). The different letters in the same rows mean significant difference (p<0.05).
3.6 Upregulation of GST A3 and Nrf2 expression
The expression of GST A3 that could catalyze the conjugation of glutathione (GSH) and AFBO was also evaluated. L. plantarum C88 significantly increased the expression of GST A3, with maximum expression in the group that received only viable L. plantarum C88 (Fig 4). The combined treatment of AFB1 and L. plantarum C88 succeeded to induce a significant increase in expression of GST A3 toward the AFB1 group. To investigate whether the increase in the expression of GST A3 was linked with the upregulation of Nrf2 expression, the expression of Nrf2 genes was further evaluated in the liver of mice. The results indicated that Nrf2 expression was highly increased in AFB1 + L. plantarum C88 treatment groups compared with that in the AFB1 group; treatment with only viable or heat-killed L. plantarum C88 increased Nrf2 level significantly (P < 0.05), and this increase was pronounced in the group received the viable L. plantarum C88; Western blot analysis confirmed the results. As the activation of Nrf2 depends on its nuclear translocation, the expression of Nrf2 was assessed in nuclear and cytoplasm fractions. After oral administration of viable and heat-killed L. plantarum C88, the expression of Nrf2 in nuclear fraction was significantly increased, indicating a nuclear translocation from cytoplasm.
GST A3 (A) and Nrf2 (B) gene expression was measured by RT-PCR. Expression of GST A3 (C), Nrf2, Cytoplasmic Nrf2 and Nuclear Nrf2 (D) and β-actin was detected by Western blot analysis. β-actin was used as a housekeeping control. The results are expressed as mean ± S.D.; each data point is the average of 3 repeated measurements from 10 independently replicated experiments (n = 10). The different letters in the same rows mean significant difference (p<0.05).
3.7 Reducing oxidative stress through modulating the Nrf2 signaling pathway
The aim of neutralization test was to clarify whether upregulation of GST A3 and enhancement of antioxidant enzyme activity were specific associated with the Nrf2 signaling pathway. As compared to the control group, administration of AFB1 not only markedly decreased the activities of different antioxidant enzymes, but also down-regulated the expression of GST A3 and Nrf2 (P < 0.05), but the reverse trend was found in the group only received L. plantarum C88 supplementation. Pretreatment with L. plantarum C88 enhanced the antioxidant capacity in supernatants and elevated the expression of GST A3 mRNA in splenocytes. With addition of anti-Nrf2 antibody, Nrf2 level was significantly decreased (P < 0.05), and the activities of different antioxidant enzymes were depressed (Fig 5A), indicating that Nrf2 strongly involved in increasing antioxidant capacity. Furthermore, the addition of anti-Nrf2 antibody significantly (P<0.05) decreased expression of GST A3 (Fig 5B).
Anti-mouse Nrf2 monoclonal antibody or L. plantarum C88 (1010 CFU/ml) were added at the beginning of the culture period. Splenocytes were cultured in the absence (control or C88) or presence (AFB1) of 2 μg/ml AFB1. T-AOC, T-SOD, GSH-Px activities in cell culture supernatants (A). GST A3 gene expression in splenocytes was measured by RT-PCR. Expression of GST A3, Nrf2 and β-actin was detected by Western blot analysis. β-actin was used as a housekeeping control (B). The results are expressed as mean ± S.D.; each data point is the average of 3 repeated measurements from 10 independently replicated experiments (n = 10). The different letters in the same rows mean significant difference (p<0.05).
Discussion
Previous studies have shown that lactobacilli have the ability to efficiently remove AFB1, but the specific detoxification mechanism is poorly understood [9–11]. This study may be the first to explore the protective mechanisms of the oral administration of lactobacilli against AFB1 chronic toxicity in mice. In this study, L. plantarum C88 was selected, which presented the highest binding ability with AFB1 using AFB1 binding assay in vitro compared with other strains. Furthermore, both viable and heat-killed L. plantarum C88 showed strong AFB1 binding activity, which guaranteed that L. plantarum C88 could exert better effects regardless of lower pH or high levels of bile salts. The presence of bile salts and intestinal tract pH affected the AFB1 binding ability of viable bacteria [19]. This is not inexplicable; a previous study pointed out that the binding activities of heat-killed bacteria were not drastically changed compared with those of viable bacteria because heat treatment might change the original binding site of the viable bacteria but expose new binding sites [20].
To further explore the detoxification effects of L. plantarum C88 on AFB1, an in vivo experiment using a mouse model was conducted with initial treatments on the first day. The presence of unabsorbed AFB1 and the number of lactobacilli in the feces showed a positive correlation, suggesting that L. plantarum C88 was able to retain additional AFB1 inside the intestinal lumen most probably by binding AFB1 to the bacterial surface. Moreover, the highest levels of fecal AFB1 and number of lactobacilli were observed at the second hour post dose, suggesting that probiotic aflatoxin binding occurs immediately after administration of AFB1. The present findings indicated that L. plantarum C88 might act as a biological barrier in the intestine under normal conditions, thereby reducing the bioavailability of AFB1 ingested orally and hence avoiding its toxic effects. Previous studies have demonstrated that L. rhamnosus GG could modulate intestinal AFB1 absorption in rats by increasing fecal AFB1 excretion [21]. Oral administration of 2 × 1010 CFU per day of L. rhamnosus LC705 in humans was followed by an increase in the fecal counts of lactobacilli [22].
The histological results reported in the current study confirmed the biochemical results and indicated that AFB1 induced severe histological changes in the liver of mice. Similar histopathological changes of AFB1 induced hepatic damage have been previously reported [23,24]. The significant recovery of hepatic tissues in mice treated with AFB1 combined with viable L. plantarum C88, as demonstrated in the histopathological sections (Fig 2D), was consistent with previous results in mice [24]. The result obviously demonstrate the potential beneficial effects of L. plantarum C88 to counteract the oxidative stress induced by AFB1.
Oxidative stress is a critical mechanism contributing to initiation and progression of hepatic damage caused by AFB1 toxicity by increasing lipid peroxidation and decreasing activities of antioxidant enzymes. T-AOC reflects the capacity of the nonenzymatic antioxidant defense system. SOD, GSH-Px, and CAT are thought to play a crucial role in the interception and degradation of superoxide anion and hydrogen peroxide. MDA is an end product and indicator of the lipid peroxidation process, which can react with biomolecules and exert cytotoxic and genotoxic effects. Viable and heat-killed L. plantarum C88 supplementation in the diet improved the activities of antioxidant enzymes and decreased lipid peroxidation in serum and liver. After feeding of viable and heat-killed L. plantarum C88 along with AFB1, the significantly increased T-AOC, SOD, GSH-Px, and CAT activities, and decreased lipid peroxidation implied that L. plantarum C88 might reverse the oxidative damage caused by AFB1 (Table 2). An in vivo study showed that probiotic fermented milk containing L. rhamnosus GG and L. casei Shirota ameliorated hepatic damage induced by AFB1 in rats by enhancing the activities of antioxidant enzymes [25]. L. casei and L. reuteri significant decreased lipid peroxidation in liver and kidney against oxidative stress in rats fed aflatoxin-contaminated diet [24]. Furthermore, previous studies indicated the elevation of antioxidant enzymes was triggered by the activation of Nrf2 signaling pathway [26]. In agreement with previous findings, we found a strong positive correlation between the activity of antioxidant enzymes and the level of Nrf2 in splenocytes cells, and suggest that Nrf2 may be capable of interacting positively to contribute to reduced oxidative stress triggered by AFB1.
It has been reported that AFB1 could be converted to AFQ1 and AFBO by CYP 3A4, or AFM1 and AFBO by CYP 1A2, to finally exert its carcinogenic effects. CYP 3A4 expression level was the most important determinant of the AFB1 disposition toward these primary metabolites [27]. AFBO reacts with nucleophilic centers in the DNA and proteins, forming covalently bound aflatoxin-N7-guanine (AFB1-N7-Gua) and lysine adducts. AFB1-DNA adduction is believed to be the source of point mutations that initiate AFB1-induced hepatocarcinogenesis [28]. The present study found that the CYP 1A2 and CYP 3A4 expression levels were decreased on administration of L. plantarum C88. Furthermore, we evaluated the urinary excretion of AFB-N7-guanine, and urinary AFB-N7-guanine was significantly reduced by presence of L. plantarum C88 (Table 2). This finding indicated that L. plantarum C88 could down-regulate the expression of CYP 1A2 and CYP 3A4 at the transcription level which further reduced AFBO concentration. Very few studies have been performed so far on the protective effects of lactobacilli against AFB1 by influencing the CYP 450 pathway. Only Gratz et al. [20] reported that L. rhamnosus GG reduced AFB1 availability in vitro by down-regulating the expression of CYP 3A4. Therefore, the present findings might provide new thought for the reduction of AFB1 toxicity by LAB.
A relevant study confirmed that AFBO could be catalyzed by GST to conjugate with GSH to form a water-soluble AFB1-GSH, which was subsequently excreted in the bile and urine [23]. As GST A3, a member of GST family, appeared to be the critical factor involved in AFB1 detoxification in mice, the expression of GST A3 was measured in mice fed L. plantarum C88; the significantly increased GST A3 level implied that L. plantarum C88 might afford significant protection against AFBO, which could further induce DNA damage and protein denaturation. L. fermentum I5007 has been shown to increase the level of detoxifying GST in Caco-2 cells [29]. Moreover, the mechanism of GST A3 activation is required to be explored. Nrf2 signaling pathway is involved in triggering the expression of many genes encoding for detoxification, cytoprotective and antioxidant enzymes. In a previous study, following oral treatment with AFB1, the downregulation of GST A3 and an increase of AFB1–DNA adducts level were observed in Nrf2 knockout mice [30]. In the present study, as shown in Real-time PCR result, after the addition of anti-Nrf2 antibody, GST A3 mRNA level was declined due to the formation of antigen antibody complex, indicating that the changes of GST A3 level depends on Nrf2 level. Therefore, we speculated that GST A3 was adjusted through Nrf2 pathway, and Western-blot result verified this speculation.
Conclusions
L. plantarum C88, a selected lactobacillus with good AFB1-binding ability in vitro, can increase fecal AFB1 excretion, reduce lipid peroxidation, and reverse deficits in antioxidant defense systems to alleviate AFB1 toxicity. L. plantarum C88 might play a role in the suppression of CYP 1A2 and CYP 3A4 expression to decrease the production of AFBO and activate GST A3 through Nrf2 signaling pathways to improve glutathione-conjugating activity and hence induce detoxification (Fig 6).
Protection mechanisms of L. plantarum C88 against AFB1 toxicity in vivo are associated with increasing fecal AFB1 excretion, decreasing AFB1 epoxidation catalyzed by CYP 1A2 and CYP 3A4, coupled with enhancing the activities of different antioxidant enzymes and GST detoxification which are connected with the Nrf2 signaling pathways.
Supporting Information
S1 Fig. Effect of L. plantarum C88 on aspartate aminotransferase (ALT) and alanine aminotransferase (AST).
The results are expressed as mean ± S.D (n = 10). The different letters in the same rows mean significant difference (p<0.05).
https://doi.org/10.1371/journal.pone.0170109.s001
(TIF)
S1 Table. Effect of L. plantarum C88 on body weight gain and feed intake.
The results are expressed as mean ± S.D (n = 15). The different letters in the same rows mean significant difference (p<0.05).
https://doi.org/10.1371/journal.pone.0170109.s002
(DOCX)
Author Contributions
- Conceptualization: LH JX SL.
- Data curation: LH CD.
- Formal analysis: LH YZ.
- Funding acquisition: SL.
- Investigation: LH CD.
- Methodology: LH JX SL.
- Project administration: JX SL.
- Resources: LH CD.
- Software: LH YZ.
- Supervision: CD JX SL.
- Validation: LH LG CN.
- Visualization: LH CN.
- Writing – original draft: LH CN.
- Writing – review & editing: LH CN JX SL.
References
- 1.
IARC. Monographs on the evaluation of carcinogenic risks in humans.International Agency for Research on Cancer (IARC). IARC Press, Lyon,France 2002, Vol. 82.
- 2. Hernandez-Mendoza A, González-Córdova AF, Vallejo-Cordoba B, Garcia HS. Effect of oral supplementation of Lactobacillus reuteri in reduction of intestinal absorption of aflatoxin B1 in rats. J Basic Microbiol. 2011;51: 263–268. pmid:21298677
- 3. Jiang Y, Jolly PE, Ellis WO, Wang JS, Phillips TD, Williams JH. Aflatoxin B1 albumin adduct levels and cellular immune status in Ghanaians. Int Immunol. 2005;17: 807–814. pmid:15944194
- 4. Gross-Steinmeyer K, Eaton DL. Dietary modulation of the biotransformation and genotoxicity of aflatoxin B1. Toxicology. 2012;299: 69–79. pmid:22640941
- 5. Eaton DL, Schaupp CM. Of mice, rats, and men: could Nrf2 activation protect against aflatoxin heptocarcinogenesis in humans? Cancer Prev Res. 2014;7: 653–657.
- 6. Rawal S, Kim JE, Coulombe RJ. Aflatoxin B1 in poultry: toxicology, metabolism and prevention. Res Vet Sci. 2010;89: 325–331.
- 7. Chang I, Kim JD. Inhibition of aflatoxin production of Aspergillus flavus by Lactobacillus casei. Mycobiology. 2007;35: 76–81. pmid:24015075
- 8. Gerbaldo GA, Barberis C, Pascual L, Dalcero A, Barberis L. Antifungal activity of two Lactobacillus strains with potential probiotic properties. FEMS Microbiol Lett. 2012;332: 27–33. pmid:22497448
- 9. El-Nezami H, Kankaanpaa P, Salminen S, Ahokas J. Ability of dairy strains of lactic acid bacteria to bind a common food carcinogen, aflatoxin B1. Food Chem Toxicol. 1998;36: 321–326. pmid:9651049
- 10. Haskard CA, El-Nezami HS, Kankaanpää PE, Salminen S, Ahokas JT. Surface binding of aflatoxin B1 by lactic acid bacteria. Appl Environ Microbiol. 2001;67: 3086–3091. pmid:11425726
- 11. Peltonen K, El-Nezami H, Haskard C, Ahokas J, Salminen S. Aflatoxin B1 binding by dairy strains of lactic acid bacteria and bifidobacteria. J Dairy Sci. 2001;84: 2152–2156. pmid:11699445
- 12. Gratz S, Täubel M, Juvonen RO, Viluksela M, Turner PC, Mykkänen H, et al. Lactobacillus rhamnosus strain GG modulates intestinal absorption, fecal excretion, and toxicity of aflatoxin B1 in rats. Appl Environ Microbiol. 2006;72: 7398–7400. pmid:16980432
- 13. Abbès S, Salah-Abbès JB, Jebali R, Younes RB, Oueslati R. Interaction of aflatoxin B1 and fumonisin B1 in mice causes immunotoxicity and oxidative stress: Possible protective role using lactic acid bacteria. J Immunotoxicol. 2015;14: 46–54.
- 14. Li S, Zhao Y, Zhang L, Zhang X, Huang L, Li D, et al. Antioxidant activity of Lactobacillus plantarum strains isolated from traditional Chinese fermented foods. Food Chem. 2012;135: 1914–1919. pmid:22953940
- 15. Choi SS, Kim Y, Han KS, You S, Oh S, Kim SH. Effects of Lactobacillus strains on cancer cell proliferation and oxidative stress in vitro. Lett Appl Microbiol. 2006,42: 452–458. pmid:16620202
- 16. Samuel MS, Sivaramakrishna A, Mehta A. Degradation and detoxification of aflatoxin B1 by Pseudomonas putida. Int Biodeter Biodegr. 2014;86: 202–209.
- 17. Mykkänen H, Zhu H, Salminen E, Juvonen RO, Ling W, Ma J, et al. Fecal and urinary excretion of aflatoxin B1 metabolites (AFQ1, AFM1 and AFB-N7-guanine) in young Chinese males. Int J Cancer. 2005;115: 879–884. pmid:15723309
- 18. Wang S, Zhu H, Lu C, Kang Z, Luo Y, Feng L, et al. Fermented milk supplemented with probiotics and prebiotics can effectively alter the intestinal microbiota and immunity of host animals. J Dairy Sci. 2012;95: 4813–4822. pmid:22916885
- 19. Hernandez-Mendoza A, Guzman-de-Peña D, Garcia HS. Key role of teichoic acids on aflatoxin B binding by probiotic bacteria. J Appl Microbiol. 2009;107: 395–403. pmid:19486416
- 20. Haskard C, Binnion C, Ahokas J. Factors affecting the sequestration of aflatoxin by Lactobacillus rhamnosus strain GG. Chem Biol Interact. 2000;128: 39–49. pmid:10996299
- 21. Gratz S, Wu QK, El-Nezami H, Juvonen RO, Mykkänen H, Turner PC. Lactobacillus rhamnosus strain GG reduces aflatoxin B1 transport, metabolism, and toxicity in Caco-2 Cells. Appl Environ Microbiol. 2007;73: 3958–3964 pmid:17449679
- 22. Hatakka K, Holma R, El-Nezami H, Suomalainen T, Kuisma M, Saxelin M, et al. The influence of Lactobacillus rhamnosus LC705 together with Propionibacterium freudenreichii ssp. shermanii JS on potentially carcinogenic bacterial activity in human colon. Int J Food Microbiol. 2008;128: 406–410. pmid:18945506
- 23. Ilic Z, Crawford D, Vakharia D, Egner PA, Sell S. Glutathione-S-transferase A3 knockout mice are sensitive to acute cytotoxic and genotoxic effects of aflatoxin B1. Toxicol Appl Pharmacol. 2010;242: 241–246. pmid:19850059
- 24. Hathout AS, Mohamed SR, El-Nekeety AA, Hassan NS, Aly SE, Abdel-Wahhab MA. Ability of Lactobacillus casei and Lactobacillus reuteri to protect against oxidative stress in rats fed aflatoxins-contaminated diet. Toxicon. 2011;58: 179–186. pmid:21658402
- 25. Kumar M, Verma V, Nagpal R, Kumar A, Behare PV, Singh B, et al. Anticarcinogenic effect of probiotic fermented milk and chlorophyllin on aflatoxin-B1-induced liver carcinogenesis in rats. Br J Nutr. 2012;107: 1006–1016. pmid:21816119
- 26. Meng X, Chen H, Wang G, Yu Y, Xie K. Hydrogen-rich saline attenuates chemotherapy-induced ovarian injury via regulation of oxidative stress. Exp Ther Med. 2015;10: 2277–2282 pmid:26668628
- 27. Kamdem LK, Meineke I, Gödtel-Armbrust U, Brockmöller J, Wojnowski L. Dominant contribution of P450 3A4 to the hepatic carcinogenic activation of aflatoxin B1. Chem Res Toxicol. 2006;19: 577–586. pmid:16608170
- 28. Yunus AW, Razzazi-Fazeli E, Bohm J. Aflatoxin B1 in affecting broiler's performance, immunity, and gastrointestinal tract: a review of history and contemporary issues. Toxins (Basel). 2011;3: 566–590.
- 29. Yang F, Wang J, Li X, Ying T, Qiao S, Li D. 2-DE and MS analysis of interactions between Lactobacillus fermentum I5007 and intestinal epithelial cells. Electrophoresis. 2007;28: 4330–4339. pmid:18004711
- 30. Kwak MK, Egner PA, Dolan PM, Ramos-Gomez M, Groopman JD, Itoh K, et al. Role of phase 2 enzyme induction in chemoprotection by dithiolethiones. Mutat Res. 2001;480: 305–315. pmid:11506823